Inicio › Cáncer de seno › Kentucky
Ensayos clínicos de Cáncer de seno en Kentucky
24 estudios sobre Cáncer de seno buscan participantes en Kentucky.
Ciudades en Kentucky
Texto oficial del estudio (inglés)
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
- Baptist Health Lexington ( Site 0050), Lexington
- Baptist Health Hamburg ( Site 0071), Lexington
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT07060807A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
- Saint Elizabeth Medical Center Edgewood-Cancer Care Center ( Site 0053), Edgewood
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT06312176A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
- University of Kentucky Chandler Medical Center, Lexington
ReclutandoFase 2
Edades de 18 en adelante · Mujeres · Actualizado el 22 sept 2026 · NCT07287098A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- Saint Elizabeth Medical Center Edgewood, Edgewood
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07174336ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
- University Medical Center, Inc. DBA University of Louisville Hospital/James Graham Brown Cancer Center, Louisville
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 17 sept 2026 · NCT07173751A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
- UofL Health Brown Cancer Center, Louisville
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 15 sept 2026 · NCT06492616A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
- Research Site, Edgewood
- Research Site, Louisville
ReclutandoFase 3
Edades de 18 a 130 · Todos los sexos · Actualizado el 8 sept 2026 · NCT07647328Toci +/- SOC Chemo for Metastatic Triple Negative and ER-positive, HER2-negative Breast Cancers
- University of Kentucky-Lexington, Lexington
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 sept 2026 · NCT05846789A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
- Baptist Health Lexington, Lexington
- Baptist Health Hamburg, Lexington
- University of Kentucky - Markey Cancer Center, Lexington
- y 2 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 sept 2026 · NCT06790693Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- CommonSpirit Saint Joseph Hospital - Bardstown, Bardstown
- Commonwealth Cancer Center-Corbin, Corbin
- Saint Elizabeth Healthcare Edgewood, Edgewood
- y 5 más
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 40 a 75 · Todos los sexos · Actualizado el 2 sept 2026 · NCT05334069Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
- King's Daughter's Medical Center, Ashland
- CommonSpirit Saint Joseph Hospital - Bardstown, Bardstown
- Baptist Health Corbin, Corbin
- y 13 más
ReclutandoFase 3
Edades de 18 a 60 · Mujeres · Actualizado el 2 sept 2026 · NCT05879926A Phase 1 Study of LNCB74 in Advanced Solid Tumors
- St. Elizabeth Healthcare, Edgewood
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 21 ago 2026 · NCT06774963E-Mindfulness Approaches for Living After Breast Cancer
- King's Daughter's Medical Center, Ashland
- CommonSpirit Saint Joseph Hospital - Bardstown, Bardstown
- CommonSpirit Saint Joseph Medical Center - East Lexington, Lexington
- y 1 más
ReclutandoFase 3
Edades de 18 a 50 · Todos los sexos · Actualizado el 4 ago 2026 · NCT06748222EXoPERT EMERALD Clinical Study
- Lexington VA Healthcare System, Lexington
- KCTL, Louisville
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 45 en adelante · Todos los sexos · Actualizado el 1 jul 2026 · NCT07186296Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
- Norton Cancer Institute, Louisville
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 jun 2026 · NCT05696626Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
- UK Markey Cancer Center, Lexington
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 11 jun 2026 · NCT05283330Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
- Mercy Health-Paducah Cancer Center, Paducah
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 18 may 2026 · NCT06757634De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
- Saint Joseph Hospital, Lexington
- Saint Joseph Radiation Oncology Resource Center, Lexington
- Saint Joseph Hospital East, Lexington
- y 1 más
ReclutandoFase 3
Edades de 50 a 70 · Todos los sexos · Actualizado el 23 abr 2026 · NCT04852887Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Flaget Memorial Hospital, Bardstown
- Saint Joseph Hospital East, Lexington
- Saint Joseph London, London
- y 2 más
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 17 mar 2026 · NCT06418204A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
- University of Kentucky Markey Cancer Center, Lexington
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 13 feb 2026 · NCT06778863cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Baptist Corbin, Corbin
- Baptist Hardin, Elizabethtown
- Baptist Lexington, Lexington
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 40 en adelante · Todos los sexos · Actualizado el 20 ene 2026 · NCT05366881EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
- St. Elizabeth Edgewood Hospital, Edgewood
- Norton Cancer Institute - Downtown, Louisville
- Baptist Health Louisville, Louisville
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 20 ene 2026 · NCT06401421S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
- Saint Joseph Hospital East, Lexington
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 8 oct 2025 · NCT03418961Study of Palliative Radiation Combined with Pembrolizumab in Unresectable Metastatic Stage IV Breast Cancer
- James Graham Brown Cancer Center, Louisville
ReclutandoFase 2
Edades de 18 en adelante · Mujeres · Actualizado el 20 feb 2025 · NCT04990921De ClinicalTrials.gov, datos obtenidos el 1 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.